4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-000581
Director sold 17,410 shares at $8.01 ($139,454)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Gautam Director | 2025-01-02 | Sale 10b5-1 | −17,410 | $8.01 | $139,454 | 2,031,476 | D |
| Open-market sales · 17,410 sh · avg $8.01 · $139,454 | |||||||
Loading xslF345X05/wk-form4_1736198539.xml…